BBNX

Beta Bionics, Inc.

Insider Trades

ActorHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Hopman MarkChief Commercial Officer
--275 shares
SellJun 4, 2026
$3.4K275 shares
$12.31
$11.63
Jones ChristyDirector
--2.8k shares
SellJun 4, 2026
$39.4K2.8k shares
$14.00
$11.63
Lezack AdamDirector
--998 shares
SellMay 22, 2026
$11.2K998 shares
$11.21
$11.63
Carney SeanDirector
--17k shares
Grant / ExerciseMay 21, 2026
Disclosure amount unavailable17k shares
--
$11.63
Dearen Danny L.Director
--17k shares
Grant / ExerciseMay 21, 2026
Disclosure amount unavailable17k shares
--
$11.63
Jones ChristyDirector
--17k shares
Grant / ExerciseMay 21, 2026
Disclosure amount unavailable17k shares
--
$11.63

News

newsfilecorp.comBeta Bionics (BBNX) Securities Investigation: Johnson Fistel Reviews Investor Losses Following Slower New Patient Start Growthnewsfilecorp.comJun 9prnewswire.comBeta Bionics (BBNX) Securities Investigation: Johnson Fistel Reviews Investor Losses Following Slower New Patient Start Growthprnewswire.comJun 8globenewswire.comRobbins LLP Reminds BBNX Stockholders of its Investigation into Beta Bionics, Inc.; Contact the Firm for Informationglobenewswire.comJun 5globenewswire.comBeta Bionics (BBNX) Securities Investigation: Johnson Fistel Reviews Investor Losses Following Slower New Patient Start Growthglobenewswire.comJun 5globenewswire.comBeta Bionics, Inc. (BBNX) Investigation: Johnson Fistel Investigates Investor Losses Following Slower New Patient Start Growthglobenewswire.comJun 4